On 15 October 2025, the NSW Supreme Court found that US pharmaceutical company, Cosette Pharmaceuticals, Inc. did not validly terminate its $672 million takeover of ASX-listed Mayne Pharma Group ...
DynoChem Platform Designed to Facilitate API Process Development and Scale-up Already used by 11 of the world’s biggest pharmaceutical companies, the DynoChem (www.scale-up.com) platform was developed ...
BERWYN, Pa.--(BUSINESS WIRE)--Amring Pharmaceuticals Inc. (“Amring”) announces its name change to Nordic Pharma, Inc. on March 4, 2024, following the change in ownership of the company from SEVER Life ...
Designing an efficient platform is crucial for any industrial process. This design process is known as process development, and it has become increasingly important in the pharmaceutical industry at ...
Royalty Pharma increased its portfolio receipts 20% year over year in the second quarter of 2025, announced a partnership with Revolution Medicines worth up to $2 billion, and completed an acquisition ...
Design space optimization and flexibility analysis are central to enhancing the robustness, efficiency and regulatory compliance of pharmaceutical manufacturing. These approaches routinely combine ...
Technological innovations throughout the past several decades have transformed the pharmaceutical manufacturing process from traditional batch production to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback